Prevalence Of Microalbuminuria Among Children Suffering From Sickle Cell Nephropathy and Sickle Cell/Beta-Thalassemia
NCT ID: NCT01092169
Last Updated: 2010-03-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
OBSERVATIONAL
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Our goal is to examine the prevalence of proteinuria and microalbuminuria as an early predictive factor of glomerular injury, among young people who suffer from SCA as well as those who suffer from combined sickle cell/beta-thalassemia.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Spleen in Sickle Cell Anemia and Sickle Cell Thalassemia
NCT00971698
Screening for Alpha Thalassemia in Healthy Volunteers
NCT02692872
Screening Patients With Sickle Cell Disease for Kidney Damage
NCT02239016
Iron Overload and Growth Velocity in Thalassemia and Sickle Cell Anemia
NCT00972231
Iron Mediated Vascular Disease in Sickle Cell Anemia Patients
NCT01239901
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Sickle cell beta
No intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients diagnosed with combined sickle cell anemia/beta-thalassemia
Exclusion Criteria
* Hypertension
* Reduced renal mass (single kidney)
* Overweight
* History of UTIs
25 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hillel Yaffe Medical Center
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Pediatrics Department, Hillel Yaffe Medical Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
64/2009
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.